Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3

American Journal of Dermatopathology

Volumn 30, Issue 1, 2008, Pages 31-33

  Parsons, Amy ^a   Sheehan, Daniel Joseph ^a,b   Sangueza, Omar P ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

D2 40; Podoplanin; Retiform hemangioendothelioma; VEGFR 3

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN RECEPTOR 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN TISSUE; LYMPH VESSEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ENDOTHELIUM, LYMPHATIC; FEMALE; HEMANGIOENDOTHELIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; SIALOGLYCOPROTEINS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 38549117369     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31815ea7c5     Document Type: Article

References (17)

1. Tan D, Kraybill W, Cheney RT, et al. Retiform hemangioendothelioma: a case report and review of the literature. J Cutan Pathol. 2005;32:634-637.
2. Calonje E, Fletcher CD, Wilson-Jones E, et al. Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol. 1994;18:115-125.
3. Duke D, Dvorak A, Harris TJ, et al. Multiple retiform hemangioendotheliomas. A low-grade angiosarcoma. Am J Dermatopathol. 1996;18:606-610.
4. Debelenko LV, Perez-Atayde AR, Mulliken JB, et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol. 2005;18:1454-1460.
5. Arai E, Kuramochi A, Tsuchida T, et al. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol. 2006;33:492-497.
6. Gomaa AH, Yaar M, Bhawan J. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics. Am J Dermatopathol. 2007;29:18-21.
7. Ordonez NG. Podoplanin: a novel diagnostic immunohistochemical marker. Adv Anat Pathol. 2006;13:83-88.
8. Hansen T, Katenkamp K, Bittinger F, et al. D2-40 labeling in lymphangiomyoma/lymphangiomyomatosis of the soft tissue: further evidence of lymphangiogenic tumor histogenesis. Virchows Arch. 2007;450:449-453.
9. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
10. Franke FE, Steger K, Marks A, et al. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. J Cutan Pathol. 2004;31:362-367.
11. Sleeman JP, Krishnan J, Kirkin V, et al. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech. 2001;55:61-69.
12. Xu H, Edwards JR, Espinosa O, et al. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol. 2004;35:857-861.
13. Fanburg-Smith JC, Michal M, Partanen TA, et al. Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels. Am J Surg Pathol. 1999;23:1004-1010.
14. Folpe AL, Veikkola T, Valtola R, et al. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol. 2000;13:180-185.
15. Fukunaga M, Endo Y, Masui F, et al. Retiform haemangioendothelioma. Virchows Arch. 1996;428:301-304.
16. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005;46:396-402.
17. McKee PH, Calonje E, Granter SR. Pathology of the Skin With Clinical Correlations. Philadelphia, PA: Elsevier Mosby; 2005.